Meningococcal Infections
Information
- Disease name
- Meningococcal Infections
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02955797 | Completed | Phase 3 | Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers | February 24, 2017 | October 26, 2017 |
| NCT00444951 | Completed | Phase 3 | Immunogenicity and Safety of Menactra® Vaccine in Adolescents in Saudi Arabia | February 2007 | February 2009 |
| NCT00450437 | Completed | Phase 3 | A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults | March 2007 | January 2008 |
| NCT00450632 | Completed | Creation of a Biotheque of Patients of Seine-Maritime With Meningococcal Infection | September 2005 | January 2011 | |
| NCT03378258 | Completed | Petechiae In Children (PIC) Study: Defining A Clinical Decision Rule for The Management Of Fever and Non-Blanching Rashes In Children Including The Role Of Point Of Care Testing For Procalcitonin & Neisseria Meningitidis DNA. | November 9, 2017 | June 30, 2019 | |
| NCT03476135 | Completed | Phase 3 | Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine in Children | February 27, 2018 | September 10, 2018 |
| NCT03547271 | Completed | Phase 3 | Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe | December 14, 2018 | May 17, 2023 |
| NCT03798574 | Completed | The Long-term Impact of Invasive Meningococcal Disease in Australian Adolescents and Young Adults | March 1, 2016 | December 31, 2022 | |
| NCT04236960 | Completed | Phase 1 | Safety Evaluation of Meningococcal Group ACYW135 Conjugate Vaccine in 2-month to 55 Years Old Population. | July 17, 2018 | November 28, 2019 |
| NCT00474487 | Completed | Phase 3 | A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults | May 2007 | February 2008 |
| NCT00616421 | Completed | Phase 3 | Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children | March 2008 | October 2009 |
| NCT00625677 | Completed | Phase 4 | Study to Evaluate the Immune Response of United Kingdom (UK) Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life | February 2008 | March 2010 |
| NCT00626327 | Completed | Phase 3 | Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy Toddlers | February 2008 | October 2010 |
| NCT00721396 | Completed | Phase 2 | Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules | August 2008 | July 2010 |
| NCT00774384 | Completed | Phase 2 | Regulation of Mucosal Immune Response to Systemic MenB Vaccine | September 2009 | November 2011 |
| NCT00850603 | Completed | Phase 4 | Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune® | October 2002 | November 2004 |
| NCT00862277 | Completed | Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine | December 2008 | December 2009 | |
| NCT00874549 | Completed | Phase 1/Phase 2 | Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years | October 2007 | October 2008 |
| NCT00937521 | Completed | Phase 2 | Safety and Immunogenicity in Dose-Ranging and Formulation-Finding Meningococcal B (MenB) Vaccine Study in 2-month-old Infants | July 2009 | February 2012 |
| NCT01239043 | Completed | Phase 2 | Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination | November 2010 | February 2012 |
| NCT01482052 | Completed | Phase 1 | Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis | November 2011 | January 2013 |
| NCT01519713 | Completed | Phase 3 | Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects | January 2012 | December 2012 |
| NCT01732627 | Completed | Phase 2 | Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older | November 12, 2012 | January 17, 2013 |
| NCT01897402 | Completed | Phase 2 | Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine | July 2013 | December 2014 |
| NCT02041663 | Completed | N/A | Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis | March 5, 2012 | July 11, 2018 |
| NCT02199691 | Completed | Phase 2 | Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents | July 22, 2014 | October 2, 2015 |
| NCT02398396 | Completed | N/A | Investigating Meningococcal Vaccines in Adults | April 2015 | June 13, 2019 |
| NCT02500511 | Completed | Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study | June 2015 | September 2015 | |
| NCT02569632 | Completed | Phase 4 | Investigating the Immunogenicity of a U.S.-Licensed Meningococcal Serogroup B Vaccine (Trumenba) | January 2015 | December 2016 |
| NCT02591290 | Completed | Phase 4 | Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult Subjects | October 20, 2015 | March 16, 2016 |
| NCT02633787 | Completed | Phase 4 | Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra® Approximately 4 Years Earlier | December 2015 | March 2016 |
| NCT02640404 | Completed | Phase 2 | Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam | June 6, 2016 | December 5, 2016 |
| NCT02699840 | Completed | Observational Safety Study of Menactra® Administered Under Standard Health Care Practice in the Russian Federation | February 2016 | July 25, 2016 | |
| NCT02712177 | Completed | Bexsero™and Routine Infant Vaccines: Effect of Coadministration on the Safety of Immunization | August 2008 | April 2019 | |
| NCT02752906 | Completed | Phase 3 | Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine | April 15, 2016 | December 19, 2016 |
| NCT02842853 | Completed | Phase 3 | Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine | July 15, 2016 | February 28, 2017 |
| NCT02842866 | Completed | Phase 3 | Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older | July 15, 2016 | February 13, 2017 |
| NCT02864927 | Completed | Phase 4 | Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea | July 21, 2016 | June 12, 2019 |
| NCT00197808 | Completed | Phase 4 | Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines | April 2005 | January 2010 |
| NCT03077438 | Completed | Phase 3 | Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years | February 17, 2017 | October 10, 2017 |
| NCT03205358 | Completed | Phase 2 | Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers | March 31, 2015 | August 19, 2015 |
| NCT04875819 | Recruiting | Phase 4 | Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV | April 28, 2021 | December 2026 |
| NCT05981599 | Recruiting | Epidemiological, Clinical and Biological Caracteristics of Patients Presenting With Invasive Meningococcal Disease | June 30, 2023 | September 30, 2023 | |
| NCT00465582 | Terminated | B14 Meningococcal Carriage in Seine-Maritime Population: Prevalence Study and Search of Risk Factors | January 2008 | April 2008 | |
| NCT02919293 | Unknown status | Phase 1/Phase 2 | Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age | August 2016 | May 2017 |
| NCT05212935 | Unknown status | A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region, Italy | May 2022 | April 2023 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D008589